UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer

EBioMedicine, 2021-12, Vol.74, p.103696-103696, Article 103696

Chinni, Sreenivasa R.

2021

Volltextzugriff (PDF)

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

Molecular cancer, 2016-11, Vol.15 (1), p.68-68, Article 68

2016

Volltextzugriff (PDF)

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

BMC cancer, 2019-10, Vol.19 (1), p.972-972, Article 972

2019

Volltextzugriff (PDF)

PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling

Molecular cancer, 2013-07, Vol.12 (1), p.85-85, Article 85

2013

Volltextzugriff (PDF)

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth

Scientific reports, 2023-11, Vol.13 (1), p.20634-13, Article 20634

2023

Volltextzugriff (PDF)

Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update

Urologic oncology, 2021-01, Vol.39 (1), p.34-40

2021

Volltextzugriff (PDF)

ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells

Clinical cancer research, 2015-06, Vol.21 (11), p.2569-2579

2015

Volltextzugriff (PDF)

CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone

Molecular cancer research, 2008-03, Vol.6 (3), p.446-457

2008

Volltextzugriff (PDF)

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

Molecular oncology, 2022-07, Vol.16 (13), p.2451-2469

2022

Volltextzugriff (PDF)

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12

The Prostate, 2006-01, Vol.66 (1), p.32-48

2006

Volltextzugriff (PDF)

Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions

Molecular cancer research, 2013-11, Vol.11 (11), p.1349-1361

2013

Volltextzugriff (PDF)

Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells

Oncogene, 2001-05, Vol.20 (23), p.2927-2936

2001

Volltextzugriff (PDF)

Akt Inactivation Is a Key Event in Indole-3-carbinol-induced Apoptosis in PC-3 Cells

Clinical cancer research, 2002-04, Vol.8 (4), p.1228-1236

2002

Volltextzugriff (PDF)

A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells

Oncogene, 2019-01, Vol.38 (3), p.332-344

2019

Volltextzugriff (PDF)

Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis

BMC urology, 2014-01, Vol.14 (1), p.12-12, Article 12

2014

Volltextzugriff (PDF)

CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells

Cancer prevention research (Philadelphia, Pa.), 2015-05, Vol.8 (5), p.365-374

2015

Volltextzugriff (PDF)

TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression

Journal of cancer science & therapy, 2012-04, Vol.4 (4)

2012

Volltextzugriff (PDF)

General Role of GDP Dissociation Inhibitor 2 in Membrane Release of Rab Proteins: Modulations of Its Functional Interactions by in Vitro and in Vivo Structural Modifications

Biochemistry (Easton), 1999-09, Vol.38 (36), p.11711-11721

1999

Volltextzugriff (PDF)

A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells

European journal of cancer (1990), 2010-06, Vol.46 (9), p.1668-1678

2010

Volltextzugriff (PDF)

Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells

Frontiers in bioscience, 2005-01, Vol.10 (1-3), p.236

2005

Volltextzugriff (PDF)

Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells

Translational oncology, 2010-06, Vol.3 (3), p.195,IN1-203,IN1

2010

Volltextzugriff (PDF)

Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism‐based selective gelatinase inhibitor

International journal of cancer, 2006-06, Vol.118 (11), p.2721-2726

2006

Volltextzugriff (PDF)

Prostate Cancer-Associated Membrane Type 1-Matrix Metalloproteinase: A Pivotal Role in Bone Response and Intraosseous Tumor Growth

The American journal of pathology, 2007-06, Vol.170 (6), p.2100-2111

2007

Volltextzugriff (PDF)

Considering race and the potential for ERG expression as a biomarker for prostate cancer

Personalized medicine, 2014-06, Vol.11 (4), p.409-412

2014

Volltextzugriff (PDF)

Abstract 5422: TMPRSS2-ERG fusions confers efficacy of enzalutamide in an in vivo bone tumor growth model

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5422-5422

2018

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(52)
Tagungsberichte
(1)

Sprache

Englisch
(53)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth

Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update

ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells

CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12

Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions

Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells

Akt Inactivation Is a Key Event in Indole-3-carbinol-induced Apoptosis in PC-3 Cells

A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells

Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis

CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells

TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression

General Role of GDP Dissociation Inhibitor 2 in Membrane Release of Rab Proteins: Modulations of Its Functional Interactions by in Vitro and in Vivo Structural Modifications

A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells

Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells

Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells

Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism‐based selective gelatinase inhibitor

Prostate Cancer-Associated Membrane Type 1-Matrix Metalloproteinase: A Pivotal Role in Bone Response and Intraosseous Tumor Growth

Considering race and the potential for ERG expression as a biomarker for prostate cancer

Abstract 5422: TMPRSS2-ERG fusions confers efficacy of enzalutamide in an in vivo bone tumor growth model

Suchergebnisse filtern